Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-03-18EMA Withdrawn: Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) (formoterol fumarate dihydrate;glycopyrronium;beclometasone dipropionate) — Chiesi Farmaceutici S.p.A.
EMA has withdrawn the COPD inhaler Riarify, a fixed-dose triple therapy containing formoterol fumarate dihydrate, glycopyrronium, and beclom…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Pulmonary Rehabilitation Program in COPD Patient [NA]
This clinical trial update notes the completed status of a pulmonary rehabilitation program for patients with chronic obstructive pulmonary …
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area [NA]
This clinical trial update reports a terminated study evaluating therapeutic education workshops for COPD patients in the North-West Val d'O…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZEPHYR® Valves Versus Endoscopic Volume Reduction With One-stage ZEPHYR® Valves [NA]
Clinical trial evaluating the rate of pneumothorax in severe emphysema comparing two-stage versus one-stage ZEPHYR valve endoscopic lung vol…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy [NA]
This clinical trial from the University of Sao Paulo General Hospital is currently recruiting to evaluate the impact of remote vital signs m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation [Phase 3]
The document reports the completion of a Phase 3 pivotal trial evaluating the efficacy, safety and tolerability of dupilumab in adults with …
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Increasing Physical Activity in COPD Through Rhythmically Enhanced Music [NA]
The clinical trial NCT03655028 tested whether rhythmically enhanced music can boost physical activity in people with Chronic Obstructive Pul…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Impact of a Mobile Phone and Educational Intervention [NA]
A completed Kent State University clinical trial evaluated the impact of a mobile phone-based intervention plus education on individuals wit…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Long-term Oxygen Therapy in Patients With Chronic Obstructive Pulmonary Disease Who Live at High Altitude [NA]
This update reports the completion of a trial evaluating long-term oxygen therapy in patients with chronic obstructive pulmonary disease liv…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD [NA]
A clinical trial comparing early extubation using extracorporeal CO2 removal (ECCO2R) with invasive mechanical ventilation in patients with …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating the antioxidant effects of N-acetylcysteine in chronic obstructive pulmonary disease has completed.
-
FDA approval · 2025-03-14FDA Approved: ACETYLCYSTEINE — Original Application (Cameron Pharmaceuticals)
FDA approves Cameron Pharmaceuticals' Acetylcysteine original application (ANDA 214177). Acetylcysteine is used as a mucolytic and as an ant…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD
A completed clinical trial investigated how various clinical parameters affect muscle oxygenation in patients with chronic obstructive pulmo…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Clinical Variables and Dyspnea and Fear of Movement in Chronic Obstructive Pulmonary Patients
A completed clinical trial evaluating clinical variables, dyspnea, and fear of movement in patients with chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic Diseases
Clinical trial NCT05168722 provides an update on how the COVID-19 pandemic affected health care delivery and patient outcomes in individuals…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Muscle Oxygenation in Chronic Obstructive Pulmonary Disease
A clinical trial evaluating muscle oxygenation in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Copd Exacerbation and Pulmonary Hypertension Trial [Phase 4]
Phase 4 clinical trial evaluating COPD exacerbation with pulmonary hypertension has completed.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients [NA]
The update describes a clinical trial evaluating a Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease, with stat…
-
FDA approval · 2025-03-12FDA Approved: ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% — Original Application (Ritedose Pharmaceuticals, LLC)
FDA approved ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% from Ritedose Pharmaceuticals under an Abbreviated New Drug Application (generic). …
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT)
The ADAPT study, which uses wearable sensors to measure physical performance in Parkinson's disease and chronic obstructive pulmonary diseas…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD [NA]
A clinical trial evaluating reduction of corticosteroid use in outpatient treatment of COPD exacerbations has been terminated. No results ar…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Prevalence and Consequences of Urinary Incontinence in People with Chronic Pulmonary Diseases Referred for Pulmonary Rehabilitation
A completed study investigating how common urinary incontinence is among people with chronic pulmonary disease referred for pulmonary rehabi…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Substudy of Protocol 2019-002498-80 - NCT04223050: Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation (O2flow-COPD) [Phase 4]
A Phase 4 substudy of Protocol 2019-002498-80 (NCT04223050) investigating mortality differences with low versus high peripheral oxygen satur…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: The Effect of Telenursing Interventions in Empowering Patients With COPD [NA]
A completed clinical trial evaluating the effect of telenursing interventions on empowerment and self-efficacy in patients with Chronic Obst…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: The Effectiveness of Two Distinct Ventilation Strategies Escalating Positive End Expiratory Pressure (PEEP) and Lung Recruitment Maneuvers in Improving Oxygenation [NA]
This clinical trial update examines the effectiveness of two ventilation strategies—escalating positive end-expiratory pressure (PEEP) and l…